v3.26.3
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2026
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Warrants Activity

The following table summarizes the Company’s warrant activity for the nine months ended September 30, 2026, not including pre-funded warrants:

 

 

 

Warrants

 

 

Weighted
Average
Exercise Price

 

Outstanding at December 31, 2025

 

 

16,895,111

 

 

$

5.66

 

Exercised (Shares Issued)

 

 

(11,184,931

)

 

 

4.64

 

Cancelled

 

 

(5,470,003

)

 

 

4.66

 

Outstanding at September 30, 2026

 

 

240,177

 

 

$

76.22

 

Schedule of Outstanding Stock Options

Transactions during the nine months ended September 30, 2026 related to stock options granted to employees and directors under Company option plans were as follows:

 

 

 

Shares

 

 

Weighted
average
exercise
price per
Share

 

 

Weighted
average
remaining
contractual life
(years)

 

 

Aggregate
intrinsic
value
(in thousands)

 

Options outstanding as of December 31, 2025

 

 

6,616,432

 

 

$

6.21

 

 

 

9.19

 

 

$

41,382

 

Granted

 

 

1,396,000

 

 

 

13.35

 

 

 

 

 

 

 

Exercised

 

 

(13,719

)

 

 

5.90

 

 

 

 

 

 

 

Forfeited/Expired

 

 

(5,543

)

 

 

40.08

 

 

 

 

 

 

 

Options outstanding as of September 30, 2026

 

 

7,993,170

 

 

$

7.44

 

 

 

8.56

 

 

$

-

 

Options exercisable at September 30, 2026

 

 

4,568,988

 

 

$

6.35

 

 

 

8.28

 

 

$

-

 

Schedule of Assumptions to Estimate Fair Value of Options Granted

The Company estimated the fair value of stock options granted during the nine months ended September 30, 2026 using the Black-Scholes option pricing model and the following range of assumptions:

 

 

 

For the nine months ended September 30, 2026

 

Risk-free interest rate

 

3.5% - 4.5%

 

Expected volatility

 

61.0% - 122.2%

 

Expected term (in years)

 

1.7 - 7.0

 

Expected dividend yield

 

 

-

 

Pre-Funded Warrants [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Warrants Activity

Pre-Funded Warrant Activity

The following table summarizes the Company’s pre-funded warrant activity for the nine months ended September 30, 2026:

 

 

 

 

Pre-funded Warrants

 

 

Weighted
Average
Exercise Price

 

Outstanding at December 31, 2025

 

 

33,102,778

 

 

$

0.01

 

Exercised (Shares Issued)

 

 

(25,018,668

)

 

 

0.01

 

Forfeited*

 

 

(12,142

)

 

 

0.01

 

Outstanding at September 30, 2026

 

 

8,071,968

 

 

$

0.01

 

*Represents shares forfeited as a result of the cashless exercise of pre-funded warrants during the period.

 

 

 

 

 

 

Inducement Stock Options  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Outstanding Stock Options

Inducement stock option activity during the nine months ended September 30, 2026 was as follows:

 

 

 

Shares

 

 

Weighted
average
exercise
price per
Share

 

 

Weighted
average
remaining
contractual life
(years)

 

 

Aggregate
intrinsic
value
(in thousands)

 

Options outstanding as of December 31, 2025

 

 

250,314

 

 

$

10.20

 

 

 

9.10

 

 

$

1,435

 

Granted

 

 

1,267,500

 

 

 

12.36

 

 

 

 

 

Options outstanding as of September 30, 2026

 

 

1,517,814

 

 

$

12.00

 

 

 

9.43

 

 

$

-

 

Options exercisable at September 30, 2026

 

 

62,774

 

 

$

19.61

 

 

 

8.29

 

 

$

-

 

Schedule of Assumptions to Estimate Fair Value of Options Granted

The Company estimated the fair value of inducement stock options granted during the nine months ended September 30, 2026 using the Black-Scholes option pricing model and the following range of assumptions:

 

 

 

For the nine months ended September 30, 2026

 

Risk-free interest rate

 

4.2% - 4.4%

 

Expected volatility

 

115.3% - 115.7%

 

Expected term (in years)

 

7.0

 

Expected dividend yield

 

 

-